Vensun Pharmaceuticals nabs $15.8 mln in Series B financing

Vensun Pharmaceuticals said Thursday that it has closed $15.8 million in Series B financing. JW Asset Management led the round. Based in Yardley, Penn., Vensus is a generic pharmaceutical company.

North AmericaUSBriefs